Dosimetric benefit of the first clinical SBRT of lymph node oligometastases on the 1.5T MR-linac

D. Winkel; G. H. Bol; A. M. Werensteijn-Honingh; M. P. W. Intven; W. S. C. Eppinga; B. Van Asselen; J. Hes; B. W. Raaymakers; I. M. Jurgenliemk-Schulz; P. S. Kroon

Dosimetric benefit of the first clinical SBRT of lymph node oligometastases on the 1.5T MR-linac

D. Winkel
, G. H. Bol
, A. M. Werensteijn-Honingh
, M. P. W. Intven
, W. S. C. Eppinga
, B. Van Asselen
, J. Hes
, B. W. Raaymakers
, I. M. Jurgenliemk-Schulz
, P. S. Kroon

Research output: Contribution to journal › Meeting Abstract › Academic

Original language	English
Pages (from-to)	S1098-S1099
Journal	Radiotherapy and Oncology
Volume	133
Publication status	Published - Apr 2019

Cite this

@article{7cd2498c05e44a28b18fffa0c6a0dc11,

title = "Dosimetric benefit of the first clinical SBRT of lymph node oligometastases on the 1.5T MR-linac",

author = "D. Winkel and Bol, \{G. H.\} and Werensteijn-Honingh, \{A. M.\} and Intven, \{M. P. W.\} and Eppinga, \{W. S. C.\} and \{Van Asselen\}, B. and J. Hes and Raaymakers, \{B. W.\} and Jurgenliemk-Schulz, \{I. M.\} and Kroon, \{P. S.\}",

year = "2019",

month = apr,

language = "English",

volume = "133",

pages = "S1098--S1099",

journal = "Radiotherapy and Oncology",

issn = "0167-8140",

publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - Dosimetric benefit of the first clinical SBRT of lymph node oligometastases on the 1.5T MR-linac

AU - Winkel, D.

AU - Bol, G. H.

AU - Werensteijn-Honingh, A. M.

AU - Intven, M. P. W.

AU - Eppinga, W. S. C.

AU - Van Asselen, B.

AU - Hes, J.

AU - Raaymakers, B. W.

AU - Jurgenliemk-Schulz, I. M.

AU - Kroon, P. S.

PY - 2019/4

Y1 - 2019/4

M3 - Meeting Abstract

SN - 0167-8140

VL - 133

SP - S1098-S1099

JO - Radiotherapy and Oncology

JF - Radiotherapy and Oncology

ER -